| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.20B | +2.4% |
| Cost of Revenue | $614.5M | -0.1% |
| R&D Expense | $158.2M | +10.5% |
| SG&A Expense | $258.3M | +4.3% |
| Operating Income | $131.3M | +6.0% |
| Pre-tax Income | $112.3M | +21.6% |
| Income Tax | $25.4M | -2.6% |
| Net Income | $86.9M | +31.1% |
| EPS (Basic) | $3.06 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $161.8M | -13.1% |
| Accounts Receivable | $266.9M | -0.3% |
| Current Assets | $900.9M | +4.5% |
| Total Assets | $1.50B | +4.0% |
| Current Liabilities | $615.2M | +9.7% |
| Long-term Debt | $538.5M | -0.7% |
| Total Liabilities | $1.22B | +4.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $135.7M | +2.9% |
| Capital Expenditures | $22.4M | -19.9% |
| Investing Cash Flow | -$5.1M | +81.6% |
| Financing Cash Flow | -$79.9M | -155.3% |
| Free Cash Flow | $113.3M | +9.0% |
| +38.5% |
| EPS (Diluted) | $3.03 | +37.7% |
| Stockholders' Equity |
| $282.6M |
| +3.4% |